Elvis G. Jacome, PA-C

Elvis Jacome practices at Epiphany Dermatology PA in Austin, Texas.

Elvis Jacome's NPI, 1720138365, was assigned on January 12, 2007. Elvis Jacome holds Texas license PA05061.

Elvis Jacome's primary practice is Epiphany Dermatology PA, at 7300 Ranch Rd 2222, Austin, TX 78730 in Travis County. The practice phone is (254) 537-1265.

Elvis Jacome's primary practice is Epiphany Dermatology PA in Austin, Texas. The medical group on file is Epiphany Dermatology. Dmand AI also links Elvis Jacome to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Elvis Jacome practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Elvis Jacome's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Elvis Jacome is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Elvis Jacome's licenses on file in 2 states: Texas and New Mexico.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, facial skin infection, hives, itchy rashes and minor head injury among the conditions Elvis Jacome treats.

CMS data shows 1,256 Medicare services from Elvis Jacome across 14 procedure codes in 2024, for 334 Medicare patients. Medicare paid $48,805 for them. Every service was in an office.

CMS counts 334 Medicare patients who saw Elvis Jacome in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Elvis Jacome's median patient age at 63, with 51% women.

In 2024, Elvis Jacome wrote 1,245 Medicare Part D claims for 366 patients. 95% of them were for generic drugs. CMS names the drug for 1,077 of them, across 20 drugs with 11 or more claims each, at $59,623 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Elvis Jacome for performance year 2024, reported as part of a group. Elvis Jacome accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 263 general payments to Elvis Jacome from 25 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 94% of the total. Incyte Corporation paid the most, $743.

Elvis Jacome is a member of AAPA.